General Information of the Compound
Compound ID
CP0456505
Compound Name
2-[4-(6-benzyl-2-pyridin-3-yl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl)piperazin-1-yl]-N,N-dimethylethanamine
    Show/Hide
Structure
Formula
C27H35N7
Molecular Weight
457.626
Canonical SMILES
CN(C)CCN1CCN(CC1)c1nc(nc2CCN(Cc3ccccc3)Cc12)-c1cccnc1
    Show/Hide
InChI
InChI=1S/C27H35N7/c1-31(2)13-14-32-15-17-34(18-16-32)27-24-21-33(20-22-7-4-3-5-8-22)12-10-25(24)29-26(30-27)23-9-6-11-28-19-23/h3-9,11,19H,10,12-18,20-21H2,1-2H3
    Show/Hide
InChIKey
CIYRGLSRGQKNHK-UHFFFAOYSA-N
Physicochemical Property
logP
2.7805
Rotatable Bonds
7
Heavy Atom Count
34
Polar Areas
51.63
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
7
Complexity
34

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 127040946
ChEMBL ID
CHEMBL3746475
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02042, Cystic fibrosis transmembrane conductance regulator
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000535 CFBE41o- Homo sapiens (Human)  1
1
EC50 = 100000 nM
   TI
   LI
   LO
   TS